CME Group plans to introduce tungsten futures by early in the first quarter of 2027, subject to all relevant regulatory reviews. The 19 October 2026 announcement describes a future contract launch, not a market already open for trading.
The proposed contract would give market participants a way to manage exposure to a specified tungsten benchmark. The important detail is that the reference is an assessment for ammonium paratungstate, or APT—not an unspecified universal price for every form of tungsten.
What CME has announced
| Item | Verified detail |
|---|---|
| Product | Tungsten futures. Source |
| Target timing | Trading to start by early Q1 2027, pending all relevant regulatory reviews. Source |
| Settlement | Financial settlement rather than physical delivery under the announced design. Source |
| Reference assessment | Fastmarkets tungsten APT, duty unpaid, CIF Rotterdam and Baltimore. Source |
| Exchange | To be listed by and subject to COMEX rules. Source |
| Trading status | Planned; this report has not verified completed regulatory reviews or a first trading day. Source |
Why the benchmark needs attention
Financial settlement means the contract’s settlement is expressed in cash rather than a requirement to deliver the physical material. That distinction does not remove price risk. A manufacturer’s actual purchase specification, location and pricing formula may differ from a futures benchmark, leaving a mismatch.
Readers should therefore examine the final contract specification before treating it as an exact offset for a physical supply agreement. This announcement is not evidence of a particular contract size, margin requirement or live bid-and-offer price; those details are not supplied here.
What to watch before trading begins
The next material developments are completed regulatory reviews and official listing and specification notices. No forecast of a tungsten price increase, guaranteed hedge outcome or issuer revenue follows from the announcement.
For another example of why a product’s contract terms matter, see CapKet’s CME cryptocurrency-contract explainer. The instruments and underlying risks are different.
Additional official record: CME’s 21 October earnings commentary, page 8. The issuer’s 21 October 2026 earnings commentary, page 8 repeats the conditional tungsten/dairy launch plans; same issuer, not independent corroboration. Observed at 2026-10-22T06:24:11.425Z.
Official evidence and scope
CME Group official document. Source observed at 2026-10-22T06:17:11.734Z. This is an AI-assisted primary-document check, not independent human editorial approval. It is not investment advice.
Recorded source observation: . This is a source-check timestamp, not a market quote or a new article update.